Rina Kashi

843 total citations
19 papers, 597 citations indexed

About

Rina Kashi is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Immunology. According to data from OpenAlex, Rina Kashi has authored 19 papers receiving a total of 597 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Radiology, Nuclear Medicine and Imaging, 9 papers in Molecular Biology and 5 papers in Immunology. Recurrent topics in Rina Kashi's work include Monoclonal and Polyclonal Antibodies Research (12 papers), Radiopharmaceutical Chemistry and Applications (9 papers) and Glycosylation and Glycoproteins Research (3 papers). Rina Kashi is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (12 papers), Radiopharmaceutical Chemistry and Applications (9 papers) and Glycosylation and Glycoproteins Research (3 papers). Rina Kashi collaborates with scholars based in United States, Israel and Netherlands. Rina Kashi's co-authors include Rosalyn D. Blumenthal, David M. Goldenberg, Robert M. Sharkey, R M Sharkey, Esther Hurwitz, David M. Goldenberg, Rimona Margalit, Dan Peer, H.R. Lindner and I. Nir and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JNCI Journal of the National Cancer Institute and Cancer Research.

In The Last Decade

Rina Kashi

19 papers receiving 576 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rina Kashi United States 15 277 175 119 92 86 19 597
C. W. Song United States 15 136 0.5× 390 2.2× 128 1.1× 119 1.3× 32 0.4× 22 882
A Vácek Czechia 16 190 0.7× 133 0.8× 60 0.5× 129 1.4× 11 0.1× 86 685
Nancy R. Clendenon United States 12 161 0.6× 175 1.0× 41 0.3× 38 0.4× 136 1.6× 24 611
Miryam A. Fragoso United States 10 36 0.1× 194 1.1× 73 0.6× 103 1.1× 57 0.7× 13 571
Katsuhiko Shinomiya Japan 13 236 0.9× 169 1.0× 24 0.2× 50 0.5× 17 0.2× 33 703
Curtis R. Kelly United States 17 93 0.3× 253 1.4× 27 0.2× 49 0.5× 59 0.7× 34 1.1k
Gautam G. Rao United States 16 48 0.2× 157 0.9× 104 0.9× 34 0.4× 44 0.5× 59 824
Georges Weissgerber Switzerland 12 383 1.4× 265 1.5× 50 0.4× 34 0.4× 14 0.2× 21 884
Pravin Rao United States 14 33 0.1× 502 2.9× 110 0.9× 75 0.8× 41 0.5× 18 875
Shinji Kariya Japan 17 146 0.5× 197 1.1× 90 0.8× 30 0.3× 71 0.8× 39 650

Countries citing papers authored by Rina Kashi

Since Specialization
Citations

This map shows the geographic impact of Rina Kashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rina Kashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rina Kashi more than expected).

Fields of papers citing papers by Rina Kashi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rina Kashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rina Kashi. The network helps show where Rina Kashi may publish in the future.

Co-authorship network of co-authors of Rina Kashi

This figure shows the co-authorship network connecting the top 25 collaborators of Rina Kashi. A scholar is included among the top collaborators of Rina Kashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rina Kashi. Rina Kashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Kaye, Joel, Tal Birnberg, Rina Kashi, et al.. (2016). Laquinimod arrests experimental autoimmune encephalomyelitis by activating the aryl hydrocarbon receptor. Proceedings of the National Academy of Sciences. 113(41). E6145–E6152. 118 indexed citations
2.
Yang, Mi, Young Bok Lee, Chang‐Ho Ahn, et al.. (2014). A novel cytidine analog, RX-3117, shows potent efficacy in xenograft models, even in tumors that are resistant to gemcitabine.. PubMed. 34(12). 6951–9. 17 indexed citations
3.
Yang, Mi, Young Bok Lee, Deog Joong Kim, et al.. (2014). Abstract 819: A novel small molecule cytidine analog, RX-3117, shows potent efficacy in xenograft models, even in tumors that are resistant to treatment with gemcitabine. Cancer Research. 74(19_Supplement). 819–819. 1 indexed citations
4.
5.
Blumenthal, Rosalyn D., et al.. (1997). Changes in Tumor Vascular Permeability in Response to Experimental Radioimmunotherapy: A Comparative Study of 11 Xenografts. Tumor Biology. 18(6). 367–377. 19 indexed citations
6.
Blumenthal, Rosalyn D., Rina Kashi, Robert M. Sharkey, & David M. Goldenberg. (1995). Quantitative and qualitative effects of experimental radioimmunotherapy on tumor vascular permeability. International Journal of Cancer. 61(4). 557–566. 30 indexed citations
7.
Blumenthal, Rosalyn D., et al.. (1994). Comparison of equitoxic radioimmunotherapy and chemotherapy in the treatment of human colonic cancer xenografts.. PubMed. 54(1). 142–51. 45 indexed citations
8.
Blumenthal, Rosalyn D., et al.. (1992). Physiological factors influencing radioantibody uptake: A study of four human colonic carcinomas. International Journal of Cancer. 51(6). 935–941. 19 indexed citations
9.
Blumenthal, Rosalyn D., Robert M. Sharkey, Rina Kashi, & David M. Goldenberg. (1991). Suppression of Tumor Vascular Activity by Radioantibody Therapy: Implications for Multiple Cycle Treatments. PubMed. 7(1). 9–16. 14 indexed citations
10.
Blumenthal, Rosalyn D., Rina Kashi, Richard Stephens, Robert M. Sharkey, & David M. Goldenberg. (1991). Improved radioimmunotherapy of colorectal cancer xenografts using antibody mixtures against carcinoembryonic antigen and colon-specific antigen-p. Cancer Immunology Immunotherapy. 32(5). 303–310. 20 indexed citations
11.
Blumenthal, Rosalyn D., I. Fand, Robert M. Sharkey, et al.. (1991). The effect of antibody protein dose on the uniformity of tumor distribution of radioantibodies: An autoradiographic study. Cancer Immunology Immunotherapy. 33(6). 351–358. 49 indexed citations
12.
Blumenthal, Rosalyn D., R M Sharkey, Rina Kashi, & David M. Goldenberg. (1989). Comparison of therapeutic efficacy and host toxicity of two different 131I‐labelled antibodies and their fragments in the GW‐39 colonic cancer xenograft model. International Journal of Cancer. 44(2). 292–300. 45 indexed citations
13.
Blumenthal, Rosalyn D., et al.. (1989). Influence of animal host and tumor implantation site on radio‐antibody uptake in the GW‐39 human colonic cancer xenograft. International Journal of Cancer. 44(6). 1041–1047. 27 indexed citations
14.
Hurwitz, Esther, et al.. (1986). A synergistic effect between anti‐idiotype antibodies and anti‐neoplastic drugs in the therapy of a murine B‐cell tumor. International Journal of Cancer. 37(5). 739–745. 11 indexed citations
15.
Hurwitz, Esther, Rina Kashi, Ruth Arnon, Meir Wilchek, & Michael Sela. (1985). The covalent linking of two nucleotide analogs to antibodies. Journal of Medicinal Chemistry. 28(1). 137–140. 23 indexed citations
16.
Hurwitz, Esther, et al.. (1983). Site‐directed chemotherapy with a drug bound to anti‐idiotypic antibody to a lymphoma cell‐surface IgM. International Journal of Cancer. 31(6). 745–748. 14 indexed citations
17.
Tsukada, Yutaka, Esther Hurwitz, Rina Kashi, et al.. (1983). EFFECT OF A CONJUGATE OF DAUNOMYCIN AND PURIFIED POLYCLONAL OR MONOCLONAL ANTIBODIES TO RAT α‐FETOPROTEIN ON THE GROWTH OF α‐FETOPROTEIN‐PRODUCING TUMOR CELLS. Annals of the New York Academy of Sciences. 417(1). 262–269. 14 indexed citations
18.
Hurwitz, Esther, Rina Kashi, & Meir Wilchek. (1982). Platinum-Complexed Antitumor Immunoglobulins That Specifically Inhibit DNA Synthesis of Mouse Tumor Cells<xref ref-type="fn" rid="FN2">2</xref><xref ref-type="fn" rid="FN3">3</xref>. JNCI Journal of the National Cancer Institute. 69(1). 47–51. 11 indexed citations
19.
Ayalon, D., I. Nir, T. CORDOVA, et al.. (1977). Acute Effect of <i>▵</i><sup>1</sup>–Tetrahydrocannabinol on the Hypothalamo-Pituitary-Ovarian Axis in the Rat. Neuroendocrinology. 23(1). 31–42. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. W. Song Breakdown of academic impact, for papers by A Vácek Breakdown of academic impact, for papers by Nancy R. Clendenon Breakdown of academic impact, for papers by Miryam A. Fragoso Breakdown of academic impact, for papers by Katsuhiko Shinomiya Breakdown of academic impact, for papers by Curtis R. Kelly Breakdown of academic impact, for papers by Gautam G. Rao Breakdown of academic impact, for papers by Georges Weissgerber Breakdown of academic impact, for papers by Pravin Rao Breakdown of academic impact, for papers by Shinji Kariya
Rankless by CCL
2026